Hydrogen(glycinato-N,O)[sulfato(2-)-O,O']ferrat(1-)
|
|
- CAS-Nr.
- 17169-60-7
- Bezeichnung:
- Hydrogen(glycinato-N,O)[sulfato(2-)-O,O']ferrat(1-)
- Englisch Name:
- Ferroglycine Sulfate
- Synonyma:
- 2-aminoacetate;2-azanylethanoate;Iron(II) glycinate;Ferroglycine sulfate;Ferrousglycinesulfate;Iron aminoacetosulfate [ferrous];2-aminoacetate,hydron,iron(2+),sulfate;hydrogen (glycinato-N,O)[sulphato(2-)-O,O']ferrate(1-)
- CBNumber:
- CB2881360
- Summenformel:
- C2H4FeNO6S
- Molgewicht:
- 225.96
- MOL-Datei:
- 17169-60-7.mol
|
Hydrogen(glycinato-N,O)[sulfato(2-)-O,O']ferrat(1-) Eigenschaften
- Dampfdruck
- 0Pa at 25℃
- Wasserl?slichkeit
- 480g/L at 20℃
- InChI
- InChI=1S/C2H4NO2.Fe.H2O4S/c3-1-2(4)5;;1-5(2,3)4/h3H,1H2,(H,4,5);;(H2,1,2,3,4)/q-1;+3;/p-2
- InChIKey
- QDNVKBLOCGKQEB-UHFFFAOYSA-L
- SMILES
- O=S1([O-][Fe+2]2(NCC(=O)[O-]2)[O-]1)=O.[H+]
- LogP
- -3.8 at 21℃
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
|
Sicherheit |
P264 |
Nach Gebrauch gründlich waschen. |
P264 |
Nach Gebrauch gründlich waschen. |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
Hydrogen(glycinato-N,O)[sulfato(2-)-O,O']ferrat(1-) Chemische Eigenschaften,Einsatz,Produktion Methoden
Originator
Ferronord,Cooper,US,1956
Definition
Iron(II) gluconate (a ferrous gluconate) is used to treat hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For patients who cannot tolerate the usual iron compounds, it is essential to have a medication that is effective and causes minimum disturbance. Ferrous gluconate is such a medicament.
Manufacturing Process
10.0 g of ferrous sulfate and 2.7 g of glycine are thoroughly mixed and
carefully heated under nitrogen to 70°C. Reaction occurs rapidly, and the
complex compound is obtained as soon as the color turns uniformly lightbrown.
After cooling to 20°C, 12.7 g of ferrous sulfate-glycine complex are
obtained, which contains 100 mg Fe++-ion sper 0.63 g.
Therapeutic Function
Hematinic
Hydrogen(glycinato-N,O)[sulfato(2-)-O,O']ferrat(1-) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Hydrogen(glycinato-N,O)[sulfato(2-)-O,O']ferrat(1-) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 17)Lieferanten
17169-60-7(Hydrogen(glycinato-N,O)[sulfato(2-)-O,O']ferrat(1-))Verwandte Suche:
- hydrogen (glycinato-N,O)[sulphato(2-)-O,O']ferrate(1-)
- Ferrousglycinesulfate
- Ferroglycine sulfate
- Iron aminoacetosulfate [ferrous]
- 2-aminoacetate
- 2-azanylethanoate
- 2-aminoacetate,hydron,iron(2+),sulfate
- Iron(II) glycinate
- 17169-60-7
- C2H5FeNO6S